Ibudilast is an anti-inflammatory drug used mainly in Japan, which acts as a phosphodiesterase inhibitor, inhibiting the PDE4 subtype to the greatest extent, but also showing significant inhibition of other PDE subtypes. From Wikipedia
Published in JAMA Network Open, the study underscores neuroimmune challenges in alcohol disorder treatment, highlighting the importance of sex-stratified, longer-term studies.
